ArticleSurgical case reports2026
Aortic Arch Mural Thrombus Concurrent with Deep Surgical-Site Infection after Colorectal Cancer Surgery in an Enhanced Recovery after Surgery Program: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAortic mural thrombus (AMT) in a non-atherosclerotic aorta is rare but potentially catastrophic and may be difficult to distinguish from septic aortic pathology when it occurs alongside a deep postoperative infection. Enhanced recovery after surgery (ERAS) shortens hospital stay and shifts the recognition of serious complications to the early post-discharge period. We report the case of a patient who underwent colorectal cancer surgery within an ERAS protocol who developed a large AMT on POD 10, coincident with CASE PRESENTATION: A 76-year-old male with stage IVc cecal adenocarcinoma and diabetes underwent robotic-assisted ileocecal resection via the ERAS pathway. Prophylactic cefmetazole was discontinued within 24 h, and the patient was discharged on POD 5 with down-trending but elevated C-reactive protein levels. On POD 10, the patient presented with fever, leukocytosis, and decreased mobility. Contrast-enhanced CT revealed a ~38-mm AMT without mural thickening, abnormal enhancement, periaortic fat stranding, aneurysmal dilatation, or complex atherosclerotic plaque, in addition to deep port-site infection and intra-abdominal abscesses. Blood cultures (two sets) remained negative, whereas abscess and wound cultures yielded
conclusionsIn this patient who underwent ERAS colorectal cancer surgery, AMT developed around POD 10 in parallel with SAG-positive deep SSI, but without aortitis or bacteremia, favoring a bland mural thrombus driven by malignancy- and sepsis-related hypercoagulability while retaining nonbacterial thrombotic endocarditis/infective endocarditis in the differential diagnosis. The case highlights PODs 7-10 as a vulnerable window in ERAS pathways and supports a focused safety bundle that includes CRP-guided discharge thresholds, selective low-dose imaging, and POD 7 ± 1 follow-up to improve early post-discharge surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.